[1] Thannickal VJ, Horowitz JC. [J]. Proceedings of the American Thoracic Society 2006. [2] Horowitz J, Thannickal V. Idiopathic Pulmonary Fibrosis:new concepts in pathogenesis and implications for drug therapy [J]. Treatments in Respiratory Medicine 2006, 5(05). [3] Selman M, Pardo A, Kaminski N. Idiopathic Pulmonary Fibrosis:Aberrant Recapitulation of Developmental Programs? [J]. PLOS MEDICINE 2008, 5(03). [4] Shimizu, Y, Dobashi, K, Iizuka, K, Horie, T, Suzuki, K, Tukagoshi, H, Nakazawa, T, Nakazato, Y, Mori, M. Contribution of small GTPase Rho and its target protein rock in a murine model of lung fibrosis. [J]. American journal of respiratory and critical care medicine 2001, 1(1). [5] Watts K, Cottrell E, Hoban P. RhoA signaling modulates cyclin D1 expression in human lung fibroblasts;im plications for idiopathic pulmonary fibrosis [J]. Respiratory Research 2006, 7(01). [6] Konigshoff M. Functional Wnt Signaling Is Increased in Idiopathic Pulmonary Fibrosis [J]. PloS ONE 2008, 3(05). [7] Chilosi M, Poletti V, Zamò A. Aberrant Wnt/β-Catenin Pathway Activation in Idiopathic Pulmonary Fibrosis [J]. American Journal of Pathology 2003, 162(05). [8] Morrisey E. Wnt Signaling and Pulmonary Fibrosis [J]. American Journal of Pathology 2003, 162(05). [9] Hardie W, Korfhagen T, Sartor M. Genomic Profile of Matrix and Vasculature Remodeling in TGF-α Induced Pul monary Fibrosis [J]. American Journal of Respiratory Cell and Molecular Biology 2007, 37(03). [10] Allen J, Spiteri M. Growth factors in idiopathic pulmonary fibrosis:relative roles [J]. Respiratory Research 2002, 3(01). [11] Willis B, Liebler J, Luby-Phelps K. Induction of Epithelial-Mesenchymal Transition in Alveolar Epithelial Ceils by Transforming Growth Factor-β1 Potential Role in Idiopathic Pulmonary Fibrosis [J]. American Journal of Pathology 2005, 166(05). [12] Willis B, Borok Z. TGF-β-induced EMT:mechanisms and implications for fibrotic lung disease [J]. American Journal of Physiology-Lung Cellular and Molecular Physiology 2007, 293(03). [13] Wang XM, Zhang Y, Kim HP, Zhou Z, Feghali-Bostwick CA, Liu F, Ifedigbo E, Xu X, Oury TD, Kaminski N, Choi AM. Caveolin-1: a critical regulator of lung fibrosis in idiopathic pulmonary fibrosis. [J]. The Journal of Experimental Medicine 2006, 13(13). [14] Allen J, Knisht R, Bloor C. Enhanced Insulin-Like Growth Factor Binding Protein-Related Protein 2(Connective Tissue Growth Factor)Expression in Patients with Idiopathic Pulmonary Fibrosis and Pulmonary Sarcoidosis [J]. American Journal of Respiratory Cell and Molecular Biology 1999, 21(06). [15] Pan L-H, Yamauchi K, Uzuki M. Type Ⅱ alveolar epithelial cells and interstitial fibmblasts express connective tissue growth factor in IPF [J]. European Respiratory Journal 2001, 17(06). [16] Agostini C, Gurrieri C. Chemokine/cytokine cocktail in idiopathic pulmonary fibrosis. [J]. Proceedings of the American Thoracic Society 2006, 4(4). [17] Daian T, Ohtsuru A, Rogounovitch T, Ishihara H, Hirano A, Akiyama Uchida Y, Saenko V, Fujii T, Yamashita S. [J]. The Journal of Investigative Dermatology 2003. [18] Kuwano K, Hagimoto N, Kawasaki M, Yatomi T, Nakamura N, Nagata S, Suda T, Kunitake R, Maeyama T, Miyazaki H, Hara N. [J]. The Journal of Clinical Investigation: The Official Journal of the American Society for Clinical Investigation 1999. [19] Miyazaki H, Kuwano K, Yoshida K. The pefforin mediated apoptotic pathway in lung injury and fibrosis [J]. Journal of Clinical Pathology 2004, 57(12). [20] DosReis G, Borges V. Role of Fas-Ligand Induced Apoptosis in Puimonary Inflammation and Injury [J]. Current Drug Targets-Inflammation and Allergy 2003, 2(02). [21] Nakashima N, Kuwano K, Maeyama T. The p53 Mdm2 association in epithelial cells in idiopathic pulmonary fibrosis and non-specific interstitial pneumonia [J]. Journal of Clinical Pathology 2005, 58(06). [22] Koli K, Myllgrniemi M, Vuorinen K. Bone Morphogenetic Protein-4 Inhibitor Gremlin Is Overexpressed in Idiopathic Pulmonary Fibrosis [J]. American Journal of Pathology 2006, 169(01). [23] Martin M, Buckenberger J, Jiang J. TGF-β1 stimulates human AT1 receptor expression in lung fibroblasts by cross talk between the Smad, p38 MAPK, JNK, and P13K signaling pathways [J]. American Journal of Physiology-Lung Cellular and Molecular Physiology 2007, 293(03). |